AllCells - San Francisco Bay Area

AllCells - San Francisco Bay Area

Alameda, California

AllCells Advantage

AllCells is the leading provider of high quality human primary blood and marrow-based cells for over 22 years. Scientific expertise and experience in the industry has enabled AllCells to optimize protocols and provide assurances that all regulatory protocols have been met for research and clinical grade products are delivered, on-time to pharmaceutical, biotech, medical device, hospitals and academic institutions around the world; while maintaining best in class products and services.

AllCells sources through its on-site, IRB-approved state-of-the-art donor and management facilities, where we collect cells and whole tissue from a large repository of recallable healthy donors which enables custom orders to be fulfilled in the shortest time in the industry. AllCells immediately processes fresh tissue in our adjacent labs to produce purified cell types; having unparalleled quality and consistency.

Consistent high viability, high purity subtypes, and guaranteed accurate cell count. AllCells is known for high quality cells and ability to customize based on some of the most unique customer requirements. AllCells – Quality Cells for Quality Science

Our Promise

To continue to pursue our passion for innovation and customer engagement, driven by a deep understanding that high quality starting material is key to better patient outcomes.

The Right Cells

The Right Cells

Superior results start with the right cells:

  • Comprehensive validation protocols
  • Unsurpassed donor screening protocols
  • Catalog covering multiple cell types within Hematology and Immunology, Cell and Gene therapy, Immuno-oncology, Cell Biology, Biomedical Research, and Drug Discovery
  • Customized services to meet project requirements
At the Right Time

At the Right Time

Special orders delivered in three days:

  • On-site blood and marrow tissue collection facilities ensure control of the supply chain
  • Delivered when you need them
  • World-wide service – now delivered faster
  • Easy ordering with real time chat & inventory checks
Made to Order

Made to Order

Flexibility and experience:

  • Cell viability and quantity to product specifications
  • Cell purity to product specifications
  • Delivered as specified, as promised, when needed
  • Clinical Grade for Allogeneic use


Founded in 1998, AllCells is a biotechnology company dedicated to providing global researchers and biomanufacturing organizations with a dependable supply of biologically relevant, high quality primary cells that enable drug discovery, development, and manufacturing of cell therapies. Leveraging its expertise in hematology and immunology cell isolations, combined with on-site whole blood and bone marrow tissue collection operations, AllCells maintains direct access to a large repository of diverse donor profiles that can be further screened and qualified for biomedical applications. Utilizing its contiguous cell processing facilities, freshly collected tissue is immediately processed into purified cell types with unparalleled quality consistency. This optimal work-flow provides for the highest viability, purity, and cell count available. Fresh or frozen cells are shipped worldwide, or fresh cells can be immediately utilized in fee-for-service cell-based assays – delivering cell culture results/data to meet client project timelines.

1998 – 2003
  • AllCells Founded in Berkeley, California by Jay Tong, M.D.
  • Published first catalog offering a wide range of products and bioservices
  • Delivered directly to local, domestic and global customers
2003 – 2008
  • Established IRB-approved, state-of-the-art donor facilities to collect cells and whole tissue from a large repository of recallable donors which enables custom orders to be fulfilled in the shortest time in the industry
  • Employed cutting-edge processing tools, such as AutoMACS and CliniMACS
  • Further diversified product portfolio by adding numerous CD34+ isolated cell products and fresh cord blood
2008 – 2013
  • Ranked among the fastest growing privately owned United States companies by Inc. 500
  • Achieved the “Fast 50 Award” award from by the United States Pan Asian American Chamber of Commerce
  • Relocated to AllCells existing Headquarters in Alameda, California
2013 – 2020
  • Began delivering GMP Clinical Grade products to the biomedical research market
  • Grand Opening of AllCells Boston offices
  • Integrated enterprise systems solutions Oracle Netsuite
  • Lonza partnership
  • Two Bi-Coastal Successful Collection Sites


Our mission is to help the researchers we support find breakthroughs in science and improve human health. Our role in that is to make sure that we deliver the highest quality hematology and immunology cell-based products and bioservices consistently, reliably, and affordably.

Our Vision is to:

  • To be the most loved -Most trusted – biotechnology company in the industry
  • Adapt to market trends to meet our customers’ special needs
  • Bring innovation and inspiration to every researcher
  • Deliver quality products and services for life science research and clinical grade applications
  • Pioneer a new way of ordering cells via AllCells webstore; with an unparalleled and customer-centric approach

Management Team


Founder and CEO

Jay Tong founded AllCells, LLC in 1998 and served as the company’s President & CEO until 2018 when he became Chairman. While working as a Research Scientist at Novartis-Systemix (Palo Alto, CA) in the 1990s, Dr. Tong recognized an industry need for a readily available commercial source of hematologic tissue such as bone marrow, cord & peripheral blood, and purified hematology & immunology primary cell types needed to support scientific research, drug discovery and development. Jay earned his M.D. from Suzhou Medical College in China, and completed graduate studies in Hematology at Henan University at Zheng Zhou. He later completed his Hematology Fellowship at the prestigious Genoa Medical School in Italy, a world leader in bone marrow transplantation. Additional post-doctoral training took Dr. Tong to Dr. Ronald Hoffman’s Lab at Indiana University Medical School at Indianapolis. Dr. Tong has published over thirty (30) peer reviewed papers relating to stem cell purification, ex vivo expansion, gene transduction, and hematopoietic stem cell transplantation.

Danny Zheng


Danny Zheng had held CEO and CFO positions in several public companies listed at the NYSE, American Stock Exchange (merged into NYSE), and OTC Markets. Danny has extensive experience in managing complex global entities, business development & transformation, finance, and SEC compliance in the information technology, consumer product, and hedge fund industries. Most recently, Danny was the CEO of GlassBridge Enterprises, Inc. a public traded investment advisor focusing on technology-driven quantitative funds.

In Danny’s early career, he worked in the computer motherboard industry and served as general manager of the Latin American region for a major brand. During his tenure, he established distribution channels throughout the Latin American region and pioneered a motherboard manufacturing facility in the Brazil free trade zone – Manaus, Amazonas.

Danny holds an MBA degree from the Wharton School at the University of Pennsylvania and a Bachelor of Arts in Accounting from Nankai University (China). Danny is also a Certified Public Accountant.


Chief Financial Officer

Ted Parenti, Chief Financial Officer, joined AllCells in May 2016. Ted brings to AllCells extensive experience in cost accounting, capital investment and budget, and forecast/analysis using ERP systems. Ted has primary responsibility for leading the company’s accounting control, financial reporting, and forecasting processes.
Prior to joining AllCells Ted served as Industrial Controller with Bio-Rad Laboratories, Inc. where he was responsible for financial control covering multiple operational sites within Bio-Rad’s life science division. Ted has held several financial management positions including Cost Accounting Manager at Peet’s Coffee & Tea, Cost Manager with The Clorox Company, Regional Finance Manager with General Mills Operations, Inc., and others.


Chief Revenue Officer

Valerie Goodwin-Adams, Chief Revenue Officer. Valerie joined AllCells in 2018 to develop and lead AllCells marketing, sales and customer success strategies. Valerie comes with more than 25 years of extensive top line revenue generating experience in FDA-regulated biotech and medical device industries. Prior to joining AllCells, Valerie held the position of Sr. Director of Global Marketing and Development at Abaxis Global Diagnostics (acquired for 2.2B) for 13 years where she built a Global Diagnostic Direct Sales, Product Management and Marketing Teams. Valerie has held product marketing and sales development positions of increasing responsibility at Agilent Technologies, DakoCytomation and Cadence Design Systems.

Valerie holds a B.A. in Communications from San Jose State University, CA, and an MBA from Brigham Young University (BYU) Marriott School of Business, UT.  In addition, Valerie holds a Digital Marketing Certificate from Cornell University and a Advanced Global Leadership Certificate from Lucas Graduate School of Business.


Director | Clinical Operations

Sheila Smith, Director of Clinical Operations, joined AllCells in July 2014. Sheila brings to AllCells over 30 years of clinical experience with emphasis in therapeutic and donor apheresis, immunology and clinical research. Additional experience includes fiscal management, state and federal regulatory compliance, development of standard operating procedures and quality programs.

Prior to joining AllCells, Sheila held the position of Apheresis Regional Manager with Fresenius Medical Care. She was responsible for the operations and clinical oversight of a Northern California mobile apheresis program serving over 65 hospitals and healthcare organizations. Sheila holds a B.S. in Nursing (Grand Valley State College, Allendale, MI) and a Hemapheresis Practitioner Certification through the American Society for Clinical Pathology.


Director | Quality Assurance & Quality Control

Cheryl Covert, Director of Quality Assurance & Quality Control. Cheryl joined AllCells in 2017 with more than 25 years of extensive quality management and compliance experience in the FDA-regulated biopharma and medical device industries. Cheryl started her career at Chiron Corporation, (since acquired by Novartis), holding several positions of increasing responsibility in quality and manufacturing. In the 10 years prior to joining AllCells, she was head of Quality Assurance for the Clinical Systems Division at Bio-Rad Laboratories. Ms. Covert directs the quality control and quality assurance processes ensuring AllCells’ Research and Clinical Operations meet applicable domestic and international regulatory requirements.

Cheryl holds a B.S. in Microbiology from San Jose State University, CA, and an MBA from St. Mary’s College, CA.


Director | Customer Success

Gavin Cummings, Director of Customer Success joined AllCells in 2019 to lead the effort to deliver a superior experience to AllCells’ Customers. Gavin is passionate about building Customer teams and aligning companies’ goals and objectives to focus on bringing value to the customer before anything else. He brings 15 years of leadership experience of large and small teams across multiple sectors. Gavin started his career with the US Air Force where he was responsible for leading aircraft maintenance operations and process improvement programs. Since then he has developed deep experience in Global Customer Success managing accounts and leading teams in various software companies.

Gavin Holds a B.S. in Business Management from the Air Force Academy.
Have a question? Let’s chat.